首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Design, synthesis and biological evaluation of novel benzo- and tetrahydrobenzo-[h]quinoline derivatives as potential DNA-intercalating antitumor agents
【24h】

Design, synthesis and biological evaluation of novel benzo- and tetrahydrobenzo-[h]quinoline derivatives as potential DNA-intercalating antitumor agents

机译:新型苯并和四氢苯甲苯并喹啉衍生物的设计,合成及生物学评价为潜在的DNA嵌入抗肿瘤剂

获取原文
获取原文并翻译 | 示例
           

摘要

A new series of benzo- and tetrahydro benzo-[h]quinoline bearing a flexible (dimethylamino)ethylcarboxamide side chain was designed and synthesized as DNA-intercalating antitumor agents. The cytotoxic activity of the synthesized compounds was evaluated against four human cancer cell lines including MCF-7, A2780, C26 and A549. In general, saturated quinolines (tetrahydrobenzo[h]quinolines) exhibited more cytotoxicity compared to their corresponding unsaturated quinolines (benzo[h]quinolines). Compound 6e showed significant cytotoxicity against all four human cancer cell lines with IC50 values ranging from 1.86 to 3.91 mu M. The interaction of the selected compounds showed significant cytotoxicity (6b, 6e, 6i and 6j) with calf thymus DNA (CT-DNA) was studied by UV and florescent spectroscopy. In general, benzo[h]quinolines showed higher interacting effect with DNA than their corresponding saturated tetrahydrobenzothiquinolines. Compound 6i exhibited the most DNA intercalating effects among the series. The apoptotic induction potential of the most cytotoxic compounds (6e, 6b and 6i) in A549 cells was studied using Annexin V-FITC/Propidium iodide staining assay. Compound 6e which showed the most cytotoxic effect against A549 cancer cells also exhibited stronger apoptotic induction activity in comparison with 6b and 6i. The docking was performed in order to study the DNA interaction properties of these compounds. According to the computational data, these compounds can interact with DNA as DNA-intercalating agents. (C) 2018 Elsevier Masson SAS. All rights reserved.
机译:一系列新的苯并 - 和四氢苯并并[h]喹啉轴承的柔性(二甲基氨基)乙基甲侧链设计并合成DNA-插入的抗肿瘤剂。合成的化合物的细胞毒性活性被对抗四种人类肿瘤细胞系,包括MCF-7,A2780,C26和A549评价。通常,与其相应的不饱和喹啉(Benzo [H]喹啉)相比,饱和喹啉(四氢苯甲酰基[H]喹啉)表现出更多细胞毒性。化合物6E显示显著针对细胞毒性的IC50值的范围为1.86至3.91微米M.所选化合物的相互作用的所有四个人癌细胞系显示出显著的细胞毒性(图6B,6E,6I和6J)与小牛胸腺DNA(小牛胸腺DNA)由紫外线和荧光光谱研究。通常,苯并[H]喹啉与DNA相比,与它们相应的饱和四氢噻嗪醇呈较高的相互作用。化合物6i在系列中表现出最多的DNA嵌入效应。使用膜蛋白V-FITC /碘化丙啶染色测定法研究A549细胞中最细胞毒性化合物(6e,6b和6i)的凋亡诱导潜力。表现出对A549癌细胞最多的细胞毒性效应的化合物6E也与6B和6I相比表现出更强的凋亡感应活性。进行对接以研究这些化合物的DNA相互作用性质。根据计算数据,这些化合物可以与DNA相互作用,作为DNA嵌入剂。 (c)2018年Elsevier Masson SAS。版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号